Niva Bupa’s IPO to open on Thursday, price band fixed at Rs 70-Rs 74
Mumbai, Nov 4 (IANS) Niva Bupa Health Insurance Company on Monday said it has fixed the price band of Rs 70-Rs 74 per equity share of face value Rs 10 each for its maiden initial public offer (IPO). The IPO will open on Thursday for subscription and close on Monday. Investors can bid for a
Mumbai, Nov 4 (IANS) Niva Bupa Health Insurance Company on Monday said it has fixed the price band of Rs 70-Rs 74 per equity share of face value Rs 10 each for its maiden initial public offer (IPO).
The IPO will open on Thursday for subscription and close on Monday. Investors can bid for a minimum of 200 equity shares, and in multiples of 200 equity shares thereafter, said the health insurer.
The IPO is a mix of fresh issue of up to Rs 800 crore and an offer of sale (OFS) up to Rs 1,400 crore by Bupa Singapore Holdings Pte. Ltd., Fettle Tone LLP.
According to Niva Bupa, the proceeds from its fresh issuance will be utilised to the extent of Rs 1,500 crore for augmentation of capital base to maintain and strengthen solvency levels and general corporate purposes.
The offer is being made through the book-building process, wherein not less than 75 per cent of the net offer shall be available for allocation on a proportionate basis to qualified institutional buyers, not more than 15 per cent of the offer shall be available for allocation to non-institutional bidders, and not more than 10 per cent of the offer shall be available for allocation to retail individual bidders.
It is the country’s third largest and second fastest-growing standalone health insurance company (SAHI) based on overall health GDPI of Rs 54.94 billion in fiscal 2024, which grew at a CAGR of 41.37 per cent from fiscal 2022 to 2024, almost double of the industry’s average.
As of June 30, Niva Bupa insured 14.99 million lives. According to Redseer, Niva Bupa’s market share in the Indian SAHI market was 16.24 per cent for Fiscal 2024, based on retail health GDPI and for the five months ended August 31, stood at 17.29 per cent.
–IANS
na/
Losing 3-0 at home is a tough pill to swallow, and it calls for introspection, says Tendulkar
Next Articleଶ୍ରୀକ୍ଷେତ୍ର ପୁରୀରେ ଭକ୍ତି ଓ ନିଷ୍ଠାର ସହିତ ପାଳିତ ହୋଇଯାଇଛି ଯମ ଦ୍ଵିତୀୟା
Related Articles
Study decodes why promising cancer treatments trigger serious side effects

स्वास्थ्य व लाइफस्टाइलStudy decodes why promising cancer treatments trigger serious side effects
New Delhi: While cancer has seen some significant advancements in treatments that have shown promise and increased lifespan, however, it also causes serious side effects, which can affect quality of life. A new study by researchers from Australia is shedding new light on the reasons behind these side effects, Xinhua news agency reported. The team
Covid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study

स्वास्थ्य व लाइफस्टाइलCovid hospitalisation, family history, lifestyle behaviours behind unexplained sudden death: ICMR study
New Delhi: Hospitalisations due to severe Covid-19 infection, a family history of sudden deaths, as well as lifestyle behaviours are some of the reasons behind the unexplained sudden death, according to a study led by the Indian Council of Medical Research (ICMR). The peer-reviewed study published in the Indian Journal of Medical Research explored factors
ICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre

स्वास्थ्य व लाइफस्टाइलICMR, AIIMS studies found no link between Covid vaccine & sudden deaths: Centre
New Delhi: Extensive studies undertaken by the Indian Council of Medical Research (ICMR), and All India Institute of Medical Sciences (AIIMS) have conclusively established no link between Covid-19 vaccines and sudden deaths, the Ministry of Health and Family Welfare said on Wednesday. Post the Covid pandemic several cases of heart attack-related death among people, especially
